Drug and device product liability litigation strategy /

Drug and device product liability litigation strategy /

Saved in:

Bibliographic Details
Author / Creator:	Herrmann, Mark.
Imprint:	Oxford ; New York : Oxford University Press, [2012] ©2012
Description:	1 online resource (xi, 524 pages)
Language:	English
Subject:	Products liability -- Medical instruments and apparatus -- United States -- Trial practice. Products liability -- Drugs -- United States -- Trial practice. Liability, Legal. Consumer Product Safety -- legislation & jurisprudence. Equipment and Supplies. Legislation, Drug. Products liability -- Drugs -- Trial practice. Products liability -- Medical instruments and apparatus -- Trial practice. United States. United States.
Format:	E-Resource Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/12587871

Hidden Bibliographic Details
Other authors / contributors:	Alden, David B.
ISBN:	9780199750245 0199750246 1306265606 9781306265607 9780199734948 0199734941
Notes:	Includes bibliographical references and index. Print version record.
Summary:	"Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"--Provided by publisher.
Other form:	Print version: Herrmann, Mark. Drug and device product liability litigation strategy 9780199734948

Table of Contents:

Introduction
The FDA's regulation of prescription drugs and devices
Pre-litigation counseling
Legal issues & theories
Consolidated proceedings
Aggregated proceedings
Class actions
Aggregated proceedings
Multidistrict litigation
Fact discovery
Expert retention and discovery
Expert testimony, Rule 702, And Daubert
Preemption
The learned intermediary doctrine
Motions In limine
Jury selection
The trial of a drug or device case.